Patient in Intellia CRISPR trial dies after being hospitalized with liver injury

Ryan Cross / endpoints - A man in his early 80s who was recently hospitalized with liver injury, a few weeks after receiving an experimental gene editing therapy, died on Wednesday ...

AI Summary: A patient enrolled in an experimental CRISPR gene‐editing trial suffered severe liver injury and later died, spurring renewed scrutiny over the trial’s safety protocols. This fatality casts a long shadow on the promise of gene‐editing therapies, proving that pioneering science can come with perilous risks.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

Statins Rarely Cause Listed Side Effects, Review Confirms / 3 months

AHA25: Breakthroughs in Cardiovascular and Cardio‐Oncology / 6 months

FDA Greenlights Subcutaneous Daratumumab for Smoldering Multiple Myeloma / 6 months

Apixaban linked to lower bleeding than rivaroxaban in head‑to‑head study / 2 months

Hormone therapy adds no clear benefit to salvage radiotherapy / 2 months

Life-extending prostate cancer drug to be offered to thousands in England / 4 months

DEA extends telehealth controlled substance flexibilities for 2026 / 4 months